Lee CC; kesselheim - Search Results

Year	Number of Results
2018	1
2020	5
2021	8
2022	1
2023	1

1

Public-sector Contributions to Novel Biologic Drugs.

Nayak RK, Lee CC, Avorn J, Kesselheim AS. Nayak RK, et al. Among authors: lee cc. JAMA Intern Med. 2021 Nov 1;181(11):1522-1525. doi: 10.1001/jamainternmed.2021.3720. JAMA Intern Med. 2021. PMID: 34279545 Free PMC article.

2

Origins and Ownership of Remdesivir: Implications for Pricing.

Lee CC, Darrow JJ, Avorn J, Kesselheim AS. Lee CC, et al. J Law Med Ethics. 2020 Sep;48(3):613-618. doi: 10.1177/1073110520958890. J Law Med Ethics. 2020. PMID: 33021169 No abstract available.

3

Cost to Medicare of Delayed Adalimumab Biosimilar Availability.

Lee CC, Najafzadeh M, Kesselheim AS, Sarpatwari A. Lee CC, et al. Clin Pharmacol Ther. 2021 Oct;110(4):1050-1056. doi: 10.1002/cpt.2322. Epub 2021 Jul 6. Clin Pharmacol Ther. 2021. PMID: 34145566

4

Clinical Development Times for Biosimilars in the United States.

Lee CC, Kesselheim AS, Sarpatwari A. Lee CC, et al. Mayo Clin Proc. 2020 Oct;95(10):2152-2154. doi: 10.1016/j.mayocp.2020.06.039. Mayo Clin Proc. 2020. PMID: 33012346

5

Variations in Generic Combination Opioid Use Across State Medicaid Programs.

Lee CC, Kesselheim AS, Avorn J. Lee CC, et al. J Gen Intern Med. 2021 Oct;36(10):3240-3242. doi: 10.1007/s11606-020-06315-x. Epub 2020 Nov 2. J Gen Intern Med. 2021. PMID: 33140274 Free PMC article. No abstract available.

6

Characteristics of Postmarketing Studies for Vaccines Approved by the US Food and Drug Administration, 2006-2020.

Moneer O, Lee CC, Avorn J, Kesselheim AS. Moneer O, et al. Among authors: lee cc. JAMA Netw Open. 2021 Apr 1;4(4):e218530. doi: 10.1001/jamanetworkopen.2021.8530. JAMA Netw Open. 2021. PMID: 33929526 Free PMC article.

7

An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19.

Kesselheim AS, Darrow JJ, Kulldorff M, Brown BL, Mitra-Majumdar M, Lee CC, Moneer O, Avorn J. Kesselheim AS, et al. Among authors: lee cc. Health Aff (Millwood). 2021 Jan;40(1):25-32. doi: 10.1377/hlthaff.2020.01620. Epub 2020 Nov 19. Health Aff (Millwood). 2021. PMID: 33211535

8

Estimated Medicaid Spending on Original and Citrate-Free Adalimumab From 2014 Through 2021.

Wang J, Lee CC, Kesselheim AS, Rome BN. Wang J, et al. Among authors: lee cc. JAMA Intern Med. 2023 Mar 1;183(3):275-276. doi: 10.1001/jamainternmed.2022.6299. JAMA Intern Med. 2023. PMID: 36716020

9

Market Exclusivity Length for Drugs with New Generic or Biosimilar Competition, 2012-2018.

Rome BN, Lee CC, Kesselheim AS. Rome BN, et al. Among authors: lee cc. Clin Pharmacol Ther. 2021 Feb;109(2):367-371. doi: 10.1002/cpt.1983. Epub 2020 Aug 7. Clin Pharmacol Ther. 2021. PMID: 32654122

10

Factors Associated With Generic Drug Uptake in the United States, 2012 to 2017.

Rome BN, Lee CC, Gagne JJ, Kesselheim AS. Rome BN, et al. Among authors: lee cc. Value Health. 2021 Jun;24(6):804-811. doi: 10.1016/j.jval.2020.12.020. Epub 2021 Apr 22. Value Health. 2021. PMID: 34119078 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

13 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year